"If the efficacy is demonstrated, we will have 100 million doses for the Brazilian population", the ministry said in a statement, explaining that it had accepted a proposal from the laboratory and the British embassy in Brazil to cooperate in the technological development of the so-called ChAdOx1 vaccine, Xinhua reported.
"It's clear that to bring COVID-19 under control, and to save lives, we need effective vaccines, diagnostics and therapeutics-in unprecedented quantities and at unprecedented speed", WHO Director-General Tedros Adhanom Ghebreyesus said. The pandemic has highlighted the importance of global solidarity and health should not be seen as a cost but an investment.
While the Director-General said the situation in the European Union has improved significantly, he underlined that COVID -19 is very much still circulating globally, with more than four million new cases in the last month.
There are at least 13 experimental vaccines in clinical trials stage now, among the 140 being developed all over the world to combat the deadly COVID-19.
A report by the Indian Express citing World Health Organization chief scientist Soumya Swaminathan said that AstraZeneca has more scope given their plans and vaccine trials. The report said that this vaccine candidate mRNA-1273 after the initiation of the second phase of clinical trials has signed a deal with Catalent Inc.
In addition to preventing countless coronavirus deaths, the World Health Organization estimates a vaccine will prevent the global economy from losing $375 each month, an economic loss that would be fueled by lockdowns to slow the spread in the absence of a preventive shot. AstraZeneca has the largest global commitment and was the leading candidate in terms of timing. Moderna also has plans to start Phase 3 trials by mid-July. Between these, the World Health Organisation (WHO) has identified Oxford's COVID-19 vaccine- AstraZeneca as the front-runner. South Africa has almost one-third of Africa's confirmed cases with more than 106,000, including more than 2,100 deaths.